William Todd Horich's most recent trade in Supernus Pharmaceuticals Inc was a trade of 4,439 Common Stock done at an average price of $55 . Disclosure was reported to the exchange on March 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 06 Mar 2026 | 4,439 | 0 (0%) | 0% | 55 | 244,145 | Common Stock |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Sale of securities on an exchange or to another person at price $ 54.00 per share. | 06 Mar 2026 | 4,438 | 4,439 (0%) | 0% | 54 | 239,652 | Common Stock |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 3,750 | 9,991 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 3,750 | 0 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 2,625 | 7,457 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 2,625 | 0 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.73 per share. | 06 Mar 2026 | 1,718 | 8,273 (0%) | 0% | 54.7 | 94,026 | Common Stock |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.73 per share. | 06 Mar 2026 | 1,216 | 6,241 (0%) | 0% | 54.7 | 66,552 | Common Stock |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,125 | 9,398 (0%) | 0% | 0 | Common Stock | |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,125 | 0 | - | - | Performance Share Unit | |
| Supernus Pharma Inc | William Todd Horich | SVP, Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.73 per share. | 06 Mar 2026 | 521 | 8,877 (0%) | 0% | 54.7 | 28,514 | Common Stock |